Stock listing
UNCY Stock Price, News, Filings & Events — Unicycive Therapeutics, Inc.
Selected listing: UNCY · NASDAQ · USD · US
This page tracks Unicycive Therapeutics, Inc.'s UNCY:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following UNCY:NASDAQ. UNCY:NASDAQ is the stock-level entry point for investors researching Unicycive Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Unicycive Therapeutics, Inc. is a public company traded under the ticker UNCY in the American market. The company has a market capitalization of approximately $144.2 million. Unicycive focuses on developing innovative therapies to address unmet medical needs.

- Ticker
- UNCY:NASDAQ
- Asset type
- Stock
- Market cap
- $146.7M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Unicycive Therapeutics, Inc. UNCY:NASDAQ stock context
This page tracks Unicycive Therapeutics, Inc.'s UNCY:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following UNCY:NASDAQ. UNCY:NASDAQ is the stock-level entry point for investors researching Unicycive Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Unicycive Therapeutics, Inc. is a public company traded under the ticker UNCY in the American market. The company has a market capitalization of approximately $144.2 million. Unicycive focuses on developing innovative therapies to address unmet medical needs.
Latest news from Unicycive Therapeutics, Inc.
Unicycive Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
September 1, 2026
Unicycive Therapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update
August 12, 2026
Unicycive Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Update
May 12, 2026
Unicycive Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference
April 9, 2026
Unicycive Therapeutics Announces Full Year 2025 Financial Results and Provides Business Update
March 30, 2026
Research Unicycive Therapeutics, Inc.
Unicycive Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for UNCY:NASDAQ.
Unicycive Therapeutics, Inc. company profile
View the public company page for Unicycive Therapeutics, Inc. on 6ix.
Unicycive Therapeutics, Inc. news
Read company news and market updates connected to Unicycive Therapeutics, Inc..
Unicycive Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Unicycive Therapeutics, Inc..